Cover Image

Targeting apoptosis via inactivation of PI3K/Akt/mTOR signaling pathway involving NF-κB by geraniin in HT-29 human colorectal adenocarcinoma cells

Chim Kei Chan, Liu Ying Tang, Bey Hing Goh, Habsah Abdul Kadir Abstract - 103 PDF - 71

Abstract


Dietary phytochemicals possess a variety of biological activities which can be widely discovered in fruits, vegetables and herbs. Geraniin, an ellagitannin is commonly found in fruits and herbs which possesses multitude of health benefits including anti-diabetic, hepatoprotective, anti-inflammatory and anticancer. However, the effects of geraniin on human colorectal adenocarcinoma cells have yet to be evaluated. This study aimed to investigate the apoptotic effects of geraniin against selected human cancer cell lines and elucidate its underlying mechanisms. Geraniin exhibited the strongest cytotoxic effect on HT-29 cells as determined by MTT assay. Events of apoptosis induced by geraniin in HT-29 cells was portrayed by apoptotic morphological changes, externalization of phosphatidylserine, DNA fragmentation and dissipation of mitochondrial membrane potential. Western blot analysis was then used to investigate the mechanisms underlying observed growth inhibition. Geraniin was found to initiate p53 activation further resulting in elevation of Bak/Bcl-xL ratio and caspase-3 activation. This eventually led to HT-29 cell death via apoptosis. Additionally, exposure of geraniin on HT-29 cells found to suppress the PI3K/Akt/mTOR pathway and suppression of NF-kB. Cumulative evidences in this study suggests that geraniin inhibited colorectal adenocarcinoma cell proliferation via apoptosis induction and suppression of PI3K/Akt/mTOR pathway. Thus, these findings provide novel mechanistic insight for the therapeutic potential of geraniin in the treatment of colorectal adenocarcinoma.


Full Text:

PDF

References


Labi V and Erlacher M. How cell death shapes cancer. Cell Death Dis 2015; 6: e1675.

Elmore S. Apoptosis: A review of programmed cell death. Toxicol Pathol 2007; 35(4): 495-516.

Ouyang L, Shi Z, Zhao S, et al., Programmed cell death pathways in cancer: A review of apoptosis, autophagy and programmed necrosis. Cell Prolif 2012; 45(6): 487-498.

Samowitz WS and Slattery ML. Missense mismatch repair gene alterations, microsatellite instability, and hereditary nonpolyposis colorectal cancer. J Clin Oncol, 2002; 20(14): 3178.

Karin M. NF-kappaB and cancer: Mechanisms and targets. Mol Carcinog 2006; 45(6): 355-361.

Green DR and Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004; 305(5684): 626-629.

Pandurangan AK, Potential targets for prevention of colorectal cancer: A focus on PI3K/Akt/mTOR and Wnt pathways. Asian Pac J Cancer Prev 2013; 14(4): 2201-2205.

Danielsen SA, Eide PW, Nesbakken A, et al. Portrait of the PI3K/AKT pathway in colorectal cancer. Biochim Biophys Acta 2015; 1855(1): 104-121.

West KA, Castillo SS, and Dennis PA. Activation of the PI3K/Akt pathway and chemotherapeutic resistance. Drug Resist Updat 2002; 5(6): 234-48.

LoPiccolo J, Blumenthal GM, Bernstein WB, et al. Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations. Drug Resist Updat 2008; 11(1-2): 32-50.

Sakamoto K, Maeda S, Hikiba Y, et al. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth. Clin Cancer Res 2009; 15(7): 2248-2258.

Wang S, Liu Z, Wang L, et al. NF-kappaB signaling pathway, inflammation and colorectal cancer. Cell Mol Immunol 2009; 6(5): 327-334.

Xia Y, Shen S, and Verma IM. NF-kappaB, an active player in human cancers. Cancer Immunol Res 2014; 2(9): 823-830.

Reinhardt HC and Schumacher B. The p53 network: Cellular and systemic DNA damage responses in aging and cancer. Trends Genet 2012; 28(3): 128-136.

Ogawara Y, Kishishita S, Obata T, et al. Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J Biol Chem 2002; 277(24): 21843-21850.

Green DR and Kroemer G. Cytoplasmic functions of the tumour suppressor p53. Nature 2009; 458(7242): 1127-1130.

Galati G and O'Brien PJ. Potential toxicity of flavonoids and other dietary phenolics: Significance for their chemopreventive and anticancer properties. Free Radic Biol Med 2004; 37(3): 287-303.

Hamalainen M, Nieminen R, Vuorela P, et al. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm 2007; 2007: 45673.

Shahat AA, Cos P, De Bruyne, et al. Antiviral and antioxidant activity of flavonoids and proanthocyanidins from Crataegus sinaica. Planta Med 2002; 68(6): 539-541.

Londhe JS, Devasagayam TP, Foo LY, et al. Antioxidant activity of some polyphenol constituents of the medicinal plant Phyllanthus amarus Linn. Redox Rep 2008; 13(5): 199-207.

Okuda T, Mori K, and Ishino M. [Constituents of Geranium thunbergii Sieg. et Zucc. VIII. Transformations of geraniin upon decoction (author's transl)]. Yakugaku Zasshi, 1979; 99(5): 505-509.

Thitilertdecha N, Teerawutgulrag A, Kilburn JD, et al. Identification of major phenolic compounds from Nephelium lappaceum L. and their antioxidant activities. Molecules 2010; 15(3): 1453-1465.

Zhang LZ, Guo YJ, Tu GZ, et al. [Studies on chemical constituents of Phyllanthus urinaria L]. Zhongguo Zhong Yao Za Zhi 2000; 25(10): 615-617.

Londhe JS, Devasagayam TP, Foo LY. et al. Geraniin and amariin, ellagitannins from Phyllanthus amarus, protect liver cells against ethanol induced cytotoxicity. Fitoterapia 2012; 83(8): 1562-1568.

Yang CM, cheng HY, Lin TC, et al. The in vitro activity of geraniin and 1,3,4,6-tetra-O-galloyl-beta-D-glucose isolated from Phyllanthus urinaria against herpes simplex virus type 1 and type 2 infection. J Ethnopharmacol 2007; 110(3): 555-558.

Li J, Wang S, Yin J, et al. Geraniin induces apoptotic cell death in human lung adenocarcinoma A549 cells in vitro and in vivo. Can J Physiol Pharmacol 2013; 91(12): 1016-1024.

Goh JXH, Tan LT, Goh JK, et al. Nobiletin and Derivatives: Functional Compounds from Citrus Fruit Peel for Colon Cancer Chemoprevention. Cancers (Basel) 2019; 11(6).

Tan HL, Chan KG, Pusparajah P, et al. Anti-Cancer Properties of the Naturally Occurring Aphrodisiacs: Icariin and Its Derivatives. Front Pharmacol 2016; 7: 191.

Chan CK, Chan G, Awang, et al. Deoxyelephantopin from Elephantopus scaber Inhibits HCT116 Human Colorectal Carcinoma Cell Growth through Apoptosis and Cell Cycle Arrest. Molecules 2016; 21(3): 385.

Tan LTH, Lee LH, Yin WF, et al. Traditional uses, phytochemistry, and bioactivities of Cananga odorata (Ylang-Ylang). Evidence-Based Complementary and Alternative Medicine 2015; 2015.

Moghadamtousi SZ, Kamarudin MNA, Chan CK, et al. Phytochemistry and biology of Loranthus parasiticus Merr, A commonly used herbal medicine. The American journal of Chinese medicine 2014; 42(01): 23-35.

Tan HL, Chan KG, Pusparajah P, et al. Anti-cancer properties of the naturally occurring aphrodisiacs: icariin and its derivatives. Frontiers in pharmacology 2016; 7: 191.

Goh JXH, Tan LTH, Goh JK, et al. Nobiletin and Derivatives: Functional Compounds from Citrus Fruit Peel for Colon Cancer Chemoprevention. Cancers 2019; 11(6): 867.

Tay KC, Tan LTH, Chan CK, et al. Formononetin: A review of its anticancer potentials and mechanisms. Frontiers in Pharmacology 2019; 10: 820.

Goh BH, Chan CK, Kamarudin MN, et al. Swietenia macrophylla King induces mitochondrial-mediated apoptosis through p53 upregulation in HCT116 colorectal carcinoma cells. Journal of ethnopharmacology 2014; 153(2): 375-385.

Moghadamtousi S, Goh BH, Chan CK, et al. Biological activities and phytochemicals of Swietenia macrophylla King. Molecules 2013; 18(9): 10465-10483.

Chan CK, Supriady H, Goh BH, et al. Elephantopus scaber induces apoptosis through ROS-dependent mitochondrial signaling pathway in HCT116 human colorectal carcinoma cells. Journal of ethnopharmacology 2015; 168: 291-304.

Tang C, Hoo PCX, Tan LTH, et al. Golden needle mushroom: A culinary medicine with evidenced-based biological activities and health promoting properties. Frontiers in pharmacology 2016; 7: 474.

Chan WK, Tan LT, Chan KG, et al. Nerolidol: A sesquiterpene alcohol with multi-faceted pharmacological and biological activities. Molecules 2016; 21(5): 529.

Tan LTH, Low LE, Tang SY, et al. A reliable and affordable 3D tumor spheroid model for natural product drug discovery: A case study of curcumin. Progress in Drug Discovery & Biomedical Science 2019; 2(1): a0000017.

Cheng HS, Ton SH, and Abdul Kadir K. Ellagitannin geraniin: A review of the natural sources, biosynthesis, pharmacokinetics and biological effects. Phytochem Rev 2017; 16(1): 159-193.

Jiang X and Wang X. Cytochrome C-mediated apoptosis. Annu Rev Biochem 2004; 73: 87-106.

Kim MY, Zhang T, and Kraus WL. Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal. Genes Dev 2005; 19(17): 1951-1967.

Abrams SL, Steelman LS, Shelton JG, et al. The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy. Cell Cycle 2010; 9(9): 1781-1791.

Johnson SM, Gulhati P, Rampy BA, et al. Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer. J Am Coll Surg 2010; 210(5): 767-768.

Garcia-Echeverria C and Sellers WR. Drug discovery approaches targeting the PI3K/Akt pathway in cancer. Oncogene 2008; 27(41): 5511-5526.

Liu P, Cheng H, Roberts TM, et al. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 2009; 8(8): 627-644.

Vassallo A, Vaccaro MC, De Tomassi N, et al. Identification of the plant compound geraniin as a novel Hsp90 inhibitor. PLoS One 2013; 8(9): e74266.

Luo JL, Kamata H and Karin M. IKK/NF-kappaB signaling: Balancing life and death--A new approach to cancer therapy. J Clin Invest 2005.; 115(10): 2625-2632.

Bharti AC, Aggarwal BB. Nuclear factor-kappa B and cancer: Its role in prevention and therapy. Biochem Pharmacol 2002; 64(5-6): 883-888.

Harikumar KB, Kunnumakkara AB, Ahn KS, et al. Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cells. Blood 2009; 113(9): 2003-2013.

Gottlieb TM, Leal JF, Seger R, et al. Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis. Oncogene 2002; 21(8): 1299-1303.

Abraham AG and O'Neill E. PI3K/Akt-mediated regulation of p53 in cancer. Biochem Soc Trans 2014; 42(4): 798-803.

Fraser M, Leung BM, Yan X, et al. p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells. Cancer Res 2003; 63(21): 7081-7088.

Boehme KA, Kulikov R, and Blattner C. p53 stabilization in response to DNA damage requires Akt/PKB and DNA-PK. Proc Natl Acad Sci U S A 2008; 105(22): 7785-7790.

Kojima K, Shimanuki M, Shikami M, et al. The dual PI3 kinase/mTOR inhibitor PI-103 prevents p53 induction by Mdm2 inhibition but enhances p53-mediated mitochondrial apoptosis in p53 wild-type AML. Leukemia 2008; 22(9): 1728-1736.

Petros AM, Gunasekera A, Xu N, et al. Defining the p53 DNA-binding domain/Bcl-x(L)-binding interface using NMR. FEBS Lett 2004; 559(1-3): 171-174.

Aziz MH, Nihal M, Fu VX, et al. Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins. Mol Cancer Ther 2006; 5(5): 1335-1341.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2019 Chim Kei Chan, Liu Ying Tang, Bey Hing Goh, Habsah Abdul Kadir

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.